August 8, 2023
Chronic complications from immunotherapies more prevalent and persistent than previously shown among melanoma survivors
A Vanderbilt study has found that chronic immunotherapy-related complications are more prevalent and persistent than previously shown among melanoma survivors.
By Tom Wilemon